# Axsome Therapeutics, Inc. (AXSM) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$167M |
| 2024 | -$281M |
| 2023 | -$232M |
| 2022 | -$180M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$63M |
| 2025-09-30 | -$46M |
| 2025-06-30 | -$37M |
| 2025-03-31 | -$57M |
| 2024-09-30 | -$63M |
| 2024-06-30 | -$78M |
| 2024-03-31 | -$67M |
| 2023-09-30 | -$62M |
| 2023-06-30 | -$65M |
| 2023-03-31 | -$6M |
| 2022-09-30 | -$42M |
| 2022-06-30 | -$39M |
| 2021-09-30 | -$33M |
| 2021-06-30 | -$31M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/AXSM/operating-income)